DCF — BROWARD HEALTH IMPERIAL POINT
Enterprise Value: $-293.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-293.2M
Enterprise Value
$-90.7M
PV of Cash Flows
$-202.6M
PV of Terminal Value
$-326.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $120.8M | $-19.4M | -16.0% | $-24.5M | $-22.3M |
| Year 2 | $124.4M | $-18.8M | -15.0% | $-24.0M | $-19.9M |
| Year 3 | $128.2M | $-18.0M | -14.0% | $-23.5M | $-17.6M |
| Year 4 | $132.0M | $-17.9M | -14.0% | $-23.5M | $-16.1M |
| Year 5 | $136.0M | $-18.1M | -13.0% | $-23.9M | $-14.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-293.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$117.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16571722599685515
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5